Last reviewed · How we verify
NCT07036822
Effects of Skeletal Anchored Maxillary Expander for Constricted Maxilla
NA trial testing Skeletal Anchored Maxillary Expander (MARPE) in Maxillary Expansion in 24 participants. Not yet recruiting.
1 December 2026
Quick facts
| Lead sponsor | Samar Hassan Mahmoud Mohamed |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 September 2025 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 December 2027 |
Drugs / interventions tested
- Skeletal Anchored Maxillary Expander (MARPE)
Conditions studied
- Maxillary Expansion — all drugs for Maxillary Expansion →
Sponsor
Samar Hassan Mahmoud Mohamed
Who can join
Adults 12 to 25, any sex, with Maxillary Expansion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of study will be Evaluation of Effects of skeletal anchored maxillary expander for constricted maxilla with different patient's age
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07036822
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Maxillary Expansion
Currently open trials in the same condition.
- NCT07411092 — Three-dimensionally Printed Hyrax Versus Conventional Hyrax for Maxillary Arch Expansion in Adolescents · NA · recruiting
- NCT05743127 — 3D-Printed Versus Laboratory-Fabricated Hyrax Expanders · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07036822 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samar Hassan Mahmoud Mohamed
- Last refreshed: 27 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07036822.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing